These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22026504)

  • 1. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study.
    Tseng HF; Liu A; Sy L; Marcy SM; Fireman B; Weintraub E; Baggs J; Weinmann S; Baxter R; Nordin J; Daley MF; Jackson L; Jacobsen SJ;
    J Intern Med; 2012 May; 271(5):510-20. PubMed ID: 22026504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Zostavax™--a cohort study in a managed care organization.
    Baxter R; Tran TN; Hansen J; Emery M; Fireman B; Bartlett J; Lewis N; Saddier P
    Vaccine; 2012 Oct; 30(47):6636-41. PubMed ID: 22963800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
    Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
    Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
    Tyring SK; Diaz-Mitoma F; Padget LG; Nunez M; Poland G; Cassidy WM; Bundick ND; Li J; Chan IS; Stek JE; Annunziato PW;
    Vaccine; 2007 Feb; 25(10):1877-83. PubMed ID: 17227688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
    Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
    JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
    Burke MS
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H; Cunningham AL; Godeaux O; Chlibek R; Diez-Domingo J; Hwang SJ; Levin MJ; McElhaney JE; Poder A; Puig-Barberà J; Vesikari T; Watanabe D; Weckx L; Zahaf T; Heineman TC;
    N Engl J Med; 2015 May; 372(22):2087-96. PubMed ID: 25916341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoster vaccine in older adults.
    Fried R
    J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
    Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ
    Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: an observational study using active surveillance.
    Phillips A; Glover C; Leeb A; Cashman P; Fathima P; Crawford N; Snelling TL; Durrheim D; Macartney K
    BMJ Open; 2021 Mar; 11(3):e043880. PubMed ID: 33766842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and disparity in zoster vaccine uptake in a managed care population.
    Hechter RC; Tartof SY; Jacobsen SJ; Smith N; Tseng HF
    Vaccine; 2013 Sep; 31(41):4564-8. PubMed ID: 23928461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of herpes zoster in CKD: a matched-cohort study based on administrative data.
    Wu MY; Hsu YH; Su CL; Lin YF; Lin HW
    Am J Kidney Dis; 2012 Oct; 60(4):548-52. PubMed ID: 22575666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination.
    Cheetham TC; Marcy SM; Tseng HF; Sy LS; Liu IL; Bixler F; Baxter R; Donahue JG; Naleway AL; Jacobsen SJ
    Mayo Clin Proc; 2015 Jul; 90(7):865-73. PubMed ID: 26051268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoster vaccine live.
    Kockler DR; McCarthy MW
    Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.